Company / R&D per Share
Beta Bionics, Inc. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$5.22
FY2025
5-year range
$3.38 / $5.22
FY2023-FY2025
Trend
+5.7%
vs FY2024
Sector context
#5 of 108
Health Care
What the data says
Among 108 Health Care companies, Beta Bionics, Inc. is in the top 5% for r&d per share. Improved from $3.38 to $5.22 over the past 2 years.
Based on SEC 10-K filings.
5.22 in FY2025. Top quartile in the Health Care sector.
Improved from $3.38 to $5.22 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 108This company $5.22 Sector average $2.07
▼
+152.0% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 5.7% year-over-year.
- Ranks #5 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.22 | +5.7% |
| FY2024 | $4.94 | +45.9% |
| FY2023 | $3.38 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026